Ingram v. Angela Intili, M.D., Ltd.

2022 IL App (1st) 210656, 208 N.E.3d 487, 462 Ill. Dec. 940
Appellate Court of Illinois·Decided May 6, 2022·No. 1-21-0656·Published·Cited by 2 cases

Opinion

2022 IL App (1st) 210656

SIXTH DIVISION

Filing Date May 6, 2022

No. 1-21-0656

IN THE

APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT

THERESA INGRAM, )

) Appeal from the

Petitioner, ) Circuit Court of ) Cook County.

v. )

) No. 19 CH 10626

ANGELA INTILI, M.D., LTD., )

) The Honorable

Respondent-Appellee, ) Anna H. Demacopoulos, ) Judge, Presiding.

(Thomas O. Plouff, Appellant). )

JUSTICE SHARON ODEN JOHNSON delivered the judgment of the court, with opinion. Presiding Justice Pierce and Justice Mikva concurred in the judgment and opinion.

OPINION

¶1 This appeal arises from the circuit court’s grant of respondent Angela Intili, M.D., Ltd.’s motion for Illinois Supreme Court Rule 137 (eff. Jan. 1, 2018) sanctions against appellant, attorney Thomas O. Plouff. On appeal, Plouff contends that the circuit court erred in granting sanctions against him for filing an Illinois Supreme Court Rule 224 (eff. Jan. 1, 2018) petition and serving said petition with an erroneous summons. For the reasons that follow, we affirm.

¶2 Briefly stated, the facts of this case are as follows. Plouff, representing petitioner Theresa Ingram, filed both a Rule 224 petition and a section 2-402 of the Code of Civil Procedure (Code) (735 ILCS 5/2-402 (West 2018)) summons for discovery against respondent on September 13, 2019. Both documents were file stamped at 12:01 p.m. by the clerk of the circuit court, and both were assigned case number 2019-CH-10626. The Rule 224 petition sought the identity of the sales representative for Bayer Essure, Inc., in connection with the sale of Essure, a medical device. The summons for discovery indicated that a complaint was filed on September 13, 2019, however, no complaint was attached to the summons nor did petitioner ever file a complaint in connection with the summons for discovery. The summons was accompanied by a chancery division general civil cover sheet.

¶3 Respondent entered its appearance through counsel on March 24, 2020, and filed several pleadings. First, respondent filed a motion to dismiss all legal proceedings against it as a respondent in discovery with prejudice because no underlying action was filed or served, in violation of section 2-402. Next, respondent filed a motion to quash the circuit court’s order, which allowed Dr. Intili to be deposed pursuant to the Rule 224 petition because the name of the sales representative had already been provided to petitioner’s counsel on October 25, 2019: nevertheless, Plouff refused to terminate the Rule 224 petition until he received certain medical records, a signed declaration or affidavit from Dr. Intili, as well as contact information for the sales representative. On November 8, 2019, the sales representative’s business card was forwarded to petitioner’s counsel, and petitioner’s medical records were sent on May 28, 2019, June 13, 2019, and September 12, 2019. However, because the records did not contain a record of the implantation procedure, petitioner’s counsel sought to depose Dr. Intili. On January 10, 2020, respondent’s counsel forwarded an affidavit from Dr. Intili related to the absence of

procedure note in petitioner’s medical records. Respondent contended that the plain language of Rule 224 only allowed for the discovery of the identification of responsible parties and entities, thus petitioner’s requests were outside the scope of the petition and further that pursuant to Rule 224, the petition expired 60 days after issuance. Ill. S. Ct. R. 224 (eff. Jan. 1, 2018). Respondent also filed a motion for Rule 137 (Ill. S. Ct. R. 137 (eff. Jan. 1, 2018)) sanctions, noting that on January 17, 2020, respondent’s counsel requested a copy of the underlying complaint that was supposed to accompany the summons in discovery, which was evidently never filed in violation of section 2-402, and reminded petitioner’s counsel that Dr. Intili’s deposition was outside the scope of a Rule 224 petition.

¶4 Petitioner subsequently filed a motion to terminate the Rule 224 proceedings against respondent, which was granted on August 31, 2020. A hearing on respondent’s motion for sanctions was held on October 29, 2020, after which, the circuit court entered a written memorandum opinion and order on November 24, 2020.

¶5 In its order, the court found that counsel for the parties communicated numerous times regarding the subject matter of the petition and summons, with respondents consistently contending that Plouff’s actions were inappropriate and not grounded in existing law. The court specifically found that the sanctionable conduct was as follows: (1) improperly issuing the summons for a respondent in discovery suit under section 2-402 when no underlying cause of action was filed, (2) improperly filing the Rule 224 petition even though a sales representative can never be charged with negligence for representations that the company was responsible for, and (3) proceeding on the expired Rule 224 that had not been extended for good cause. The circuit court noted that although petitioner argued at the hearing that it was not a respondent in discovery action, petitioner’s counsel referred to it as such on two separate

occasions. The court found that petitioner clearly intended and referenced this litigation as a respondent in discovery matter, failed to meet the minimum statutory requirements of section 2-402 of the Code (735 ILCS 5/2-402 (West 2018)), and failed to follow the mandates of Rule 224 as petitioner’s counsel’s actions were outside the scope of the rule. The court also found that petitioner’s counsel admitted to the sanctionable conduct on multiple occasions in his declaration filed on November 4, 2020: admitting that the summons should not have been issued pursuant to section 2-402 and that if the pleadings had been amended such conduct could have been avoided and the reason to amend the petition was mooted. The court concluded that good cause existed to impose Illinois Supreme Court Rule 137 (eff. Jan. 1, 2018) sanctions against petitioner and her counsel because they knew that such conduct was impermissible yet continuously circumvented the discovery process and required respondent to engage in litigation where none was warranted. Sanctions were subsequently granted in favor of respondent and against Plouff for $12,783.56, representing respondent’s attorney fees and costs, on May 5, 2021. Plouff’s timely appeal followed.

¶6 On appeal, Plouff contends that the circuit court erred in granting respondent’s motion for Rule 137 sanctions against him for serving an erroneous summons with a Rule 224 petition. He argues that Rule 137 sanctions are improper for mistake or inadvertent actions and further that a court cannot impose such sanctions based on a summons when such summons was not a pleading signed by an attorney and did not cause any harm. Plouff contends that the erroneous summons amounted to a “misnomer,” for which Illinois forgives misnaming a party. He maintains that there was a simple mistake made in issuing the wrong summons and that “there is a reason it is called the ‘practice of law’ ” and the lesson learned here is that “a lawyer should doublecheck the summons generated by the paralegal, a member of the team who was simply

trying to do her job without bothering the supervising lawyer with what some could consider the minutiae in filing a case.”

Free access — add to your briefcase to read the full text and ask questions with AI

Ingram v. Angela Intili, M.D., Ltd., 2022 IL App (1st) 210656, 208 N.E.3d 487, 462 Ill. Dec. 940 (Ill. Ct. App. 2022).

2022 IL App (1st) 210656 (Ingram v. Angela Intili, M.D., Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Williams v. McAllister Nursing & Rehab, LLC
2024 IL App (1st) 231805 (Appellate Court of Illinois, 2024)
Daniel v. Drury Hotels Co., LLC
2024 IL App (5th) 230090-U (Appellate Court of Illinois, 2024)